Loading
A registry of up to 25,000 people who have the Exact Sciences multi-cancer blood test, following what happens after their results.
Falcon Registry (NCT06589310) is an observational study sponsored by Exact Sciences Corporation. It is a multi-site registry of patients receiving the Exact Sciences multi-cancer early detection test.
The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 25,000 participants, a start on 1 August 2024 and primary completion expected in August 2030.
Shares Cancerguard, Exact Sciences (Abbott), Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Exact Sciences (Abbott), Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Cancerguard, Exact Sciences (Abbott), Multi-cancer early detection (MCED).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/